466 abstracts found.



Results filter

Venous thromboembolism (VTE) in pancreatic cancer patients – single centre experience

Year:

Session type:

Ankit Rao1, Jing Hoay1, Tahir Shafiq1, Syed Karim1, Sarah Widdowson2, Junaid Mobeen2, Arvind Arora2
1Nottingham City Hospital, 2Nottingham University Hospitals NHS Trust

Impact of Tucatinib on Progression Free Survival in Patients with HER2+ Metastatic Breast Cancer and Brain Metastases

Year:

Session type:

Thomas Bachelot1, Nancy Lin2, Rashmi Murthy3, Sara Hurvitz4, Virginia Borges4, Mafalda Oliveira4, Catherine Oakman4, Sarah Khan5, Cynthia Lynch4, Kelly Westbrook4, Catherine Doyle4, Matthea Reinish4, Marco Colleoni4, Dennis Slamon4, Gabriel Hortobagyi3, Eric Winer2, Jorge Ramos4, Wentao Feng4, Sibylle Loibl4
1Centre Léon Bérard, 2Dana-Farber Cancer Institute, 3MD Anderson Cancer Center, 4Other, 5Nottingham University Hospitals NHS Trust

The role of genomic profiling by FoundationOne Liquid biopsy in matching patients to targeted early phase drug trials

Year:

Session type:

Laura Fitzgerald1, Lisa Brown-Schofield2, Alison Bridgewood2, Linda Hogarth2, Ruth Plummer2, Alastair Greystoke2, Yvette Drew2
1Newcastle University, 2Newcastle ECMC

Gold standard – Complete mesocolic excision (CME) for colon cancer in Georgia and Germany

Year:

Session type:

Archil Aladashvili1, Werner Hohenberger2, Roland Croner2
1Tbilisi State medical University, 2University Hospital Erlangen (Universitätsklinikum Erlangen)

The receptor for hyaluronan-mediated motility as a regulator of drug sensitivity in triple-negative breast cancer

Year:

Session type:

Britney Messam1, Eva Turley2, Andrew Nelson3, James McCarthy3
1Western University (ON), 2Other, 3University of Minnesota

Evaluating an interactive acceptance and commitment therapy (ACT) workshop for trained therapists working with cancer patients

Year:

Session type:

Elisavet Moschopoulou1, Debbie Brewin2, Damien Ridge3, Sheila Donovan1, Stephanie Taylor1, Liam Bourke4, Gail Eva5, Imran Khan1, Trudie Chalder6
1Queen Mary University of London, 2Other, 3University of Westminster, 4Sheffield Hallam University, 5Oxford Brookes University, 6King’s College London (KCL)

Achieving consensus on the relevant social outcomes for childhood cancer survivors: a Delphi study protocol

Year:

Session type:

Sarah Milner1, Kate Absolom1, Richard Feltbower1, Adam Glaser1
1University of Leeds

Cancer screening in the transgender population: a scoping review of uptake, barriers and healthcare professional knowledge

Year:

Session type:

Adele Atkins1, Helena Harder2
1Brighton and Sussex Medical School, 2Other

CovGCT:  a Phase 2 prospective analysis on Covid19-adopted Etoposide (E) and Cisplatin (P) regimens for patients (pts) with an advanced germ cell tumour (GCT)

Year:

Session type:

Nabeel Naban1, Gesa Tiemeier1, Siobhan Cleary1, Sarah Mahmood1, Arwa Kocache1, Rory Taylor1, Georgina Keogh1, Lindsay Hennah1, Naveed Sarwar1, Michael Seckl1, Michael Gonzalez1
1Imperial College Healthcare NHS Trust

Finding My Way UK: Adaptation and replication testing of the benefits of online psychological support for UK cancer survivors (protocol).

Year:

Session type:

Nick Hulbert-Williams1, Monica Leslie1, Lee Hulbert-Williams1, Bogda Koczwara2, Eila Watson3, Peter Hall4, Laura Ashley5, Neil Coulson6, Richard Jackson7, Sue Millington8, Lisa Beatty2
1University of Chester, 2Flinders University, 3Oxford Brookes University, 4Edinburgh Cancer Centre, 5Leeds Beckett University, 6University of Nottingham, 7Liverpool Cancer Trials Unit, 8No affiliation

RE-ARM – a multicentre phase II randomised controlled trial of radiotherapy plus atezolizumab in metastatic urothelial carcinoma – investigating the abscopal effect

Year:

Session type:

Robert Huddart1, Hannah Gribble1, Rebecca Lewis1, Solomon Brown1, Eleanor Cheadle2, Ananya Choudhury2, Simon Crabb3, Charlotte Emery1, Jo Haviland1, Timothy Illidge2, Mark Linch4, Henry Scowcroft5, Aslam Sohaib6, Isabel Syndikus7, Richard Walshaw2, Anna Wilkins1, Alan Melcher1, Emma Hall1
1Institute of Cancer Research (ICR), 2University of Manchester, 3University of Southampton, 4University College London (UCL), 5No affiliation, 6Royal Marsden NHS Foundation Trust, 7Clatterbridge Cancer Centre NHS Foundation Trust

IL-17, IL-22, TGF-beta,VEGF and EGFR in gastric cancer patients treated by HIPEC

Year:

Session type:

Archil Aladashvili1, Roland Croner2, Ia Pantsulaia3
1Tbilisi State medical University, 2University Hospital for Tumors, 3Tbilisi State Medical University

Feasibility, acceptability, and efficacy of online supportive care for individuals living with and beyond lung cancer: a systematic review.

Year:

Session type:

Jordan Curry1, Michael Patternson1, Sarah Greenley1, Mark Pearson1, Cynthia Forbes1
1Hull York Medical School

Identification of urine derived lymphocytes as a non-invasive measure of the tumour immune microenvironment in bladder cancer

Year:

Session type:

Yien Ning Sophia Wong1
1University College London (UCL) – Cancer Institute

Breast doses received by young women treated for Hodgkin lymphoma between 2007 and 2018: a single institutional study

Year:

Session type:

Hannah Chamberlin1, Susan Astley1, Richard Cowan2, Christina Hague2, Sacha J Howell2, John A Radford1, Sean Tenant2, Joanna LR Williams1, Marianne C Aznar1
1University of Manchester, 2The Christie NHS Foundation Trust

Safety and efficacy of lenvatinib as first-line systemic therapy for advanced hepatocellular carcinoma – a real-world single-centre retrospective analysis

Year:

Session type:

Onyinyechi Duru1, Avinash Segaran2, Ankit Rao2, Junaid Mobeen2, Sarah Widdowson2, Arvind Arora2
1Nottingham City Hospital, 2Nottingham University Hospitals NHS Trust

Patient and treatment factors associated with adverse quality of life 2 years following radiotherapy – results from the REQUITE breast cancer patient cohort

Year:

Session type:

Tim Rattay1, Harkeran Jandu2, Colin Veal2, Petra Seibold3, David Azria4, Ananya Chaudhury5, Alison Dunning6, Dirk de Ruysscher4, Sara Gutierrez-Henriquez7, Philippe Lambin8, Tiziana Rancati4, Barry Rosenstein9, Elena Sperk4, R Paul Symonds2, Christopher Talbot2, Riccardo Valdagni4, Ana Vega4, Liv Veldeman4, Adam Webb2, Hilary Stobart4, Catharine West10
1University of Leicester, Leicester, UK, 2University of Leicester, 3German Cancer Research Center (DKFZ), 4Other, 5The Christie NHS Foundation Trust, 6University of Cambridge, 7Vall d’Hebron Institute of Oncology, 8Maastricht University, 9Icahn School of Medicine at Mount Sinai (ISMMS), 10University of Manchester

Efficacy of avelumab + axitinib (A + Ax) vs sunitinib (S) by IMDC risk group in advanced renal cell carcinoma (aRCC): extended follow-up results from JAVELIN Renal 101

Year:

Session type:

John Haanen1, James Larkin2, Toni Choueiri3, Laurence Albiges1, Brian Rini4, Michael Atkins1, Manuela Schmindinger1, Konstantin Penkov1, Despina Thomaidou1, Jing Wang5, Mariangela Mariani1, Alessandra di Pietro1, Robert Motzer6
1Other, 2Royal Marsden NHS Foundation Trust, 3Dana-Farber Cancer Institute, 4Vanderbilt-Ingram Cancer Center, 5Pfizer, 6Memorial Sloan-Kettering Cancer Center

Assessment of response and toxicity for recurrent glioblastoma to single-agent Lomustine (CCNU) – A single centre experience

Year:

Session type:

Chevonne Tan1, Helen Wong2, Helen Flint2, Eswar Chinnamani2, Chloe May2, Aditya Shenoy2, Shaveta Mehta2
1Hull University Teaching Hospitals NHS Trust, 2Clatterbridge Cancer Centre NHS Foundation Trust

Optimising the delivery of breast cancer risk estimates to women aged 30-39 years: women’s views

Year:

Session type:

Sarah Bellhouse1, Louise Gorman1, Sacha Howell1, Rhiannon Hawkes1, David French1
1University of Manchester

Quality of life in adults with low grade gliomas: a systematic review

Year:

Session type:

Ben Rimmer1, Iakov Bolnykh1, Lizzie Dutton1, Fiona Menger1, Linda Sharp1
1Newcastle University

CREDIT (Cancer Related Escalation Decisions for ITU) Study; Survival, functional status and return to anti-cancer therapy in advanced solid tumour patients after emergency admission to critical-care

Year:

Session type:

Rachel Marshall1, Alec Maynard1, Bilal Tahir2, Hayley Boyce1, Richard Harrold1, Martha Eldridge1, Jessica Johnson1, Danielle Meehan1, Rachel Spiro1, Amanda Swan3, Anna Ratcliffe4, Helena Jennison4, Sarah Kingdon4, Andrew Cruikshanks1, Caroline Wilson1
1Sheffield Teaching Hospitals NHS Foundation Trust, 2University of Sheffield, 3Edinburgh Cancer Centre, 4Derriford Hospital

Volunteers as lifestyle coaches in a clinical trial – experiences from Breast Cancer Now on the ActWELL trial

Year:

Session type:

Amy Hickman1, Hanne Bruhn2, Shaun Treweek2, Annie. S Anderson3
1Breast Cancer Now, 2University of Aberdeen, 3University of Dundee

Neutropenic Sepsis One Hour Door-To-Needle Target in the Emergency Department: A Clinical Audit During the Covid-19 Pandemic

Year:

Session type:

Jonathan Martin1, Claire Pettinger2, Benjamin Mckechnie2, Lee Grimes2, Simon Hunter2, Margaret Pople2, Effie Grand2
1University of Southampton, 2Salisbury NHS Foundation Trust

ATNEC: A multicentre, randomised trial investigating whether axillary treatment can be avoided in patients with no residual cancer in the lymph glands after neoadjuvant chemotherapy

Year:

Session type:

Amit Goyal1, Janet Dunn2, Sophie Cramp2, Andrea Marshall2, Duncan Wheatley3, Natalie Hammonds2, Shama Puri1, Tara Homer4, Luke Vale4, Romaana Mir5, Janice Rose6, Helen Teresa Edwards7, Samreen Ahmed8, Abeer Shaaban9, Beatrix Elsberger10, Julie Bruce2, Sophie Gasson2, Valerie Speirs11, Jacqui Shaw12, Helen Higgins2
1University Hospitals of Derby and Burton NHS Foundation Trust, 2University of Warwick, 3Royal Cornwall Hospitals NHS Trust, 4Newcastle University, 5Mount Vernon Cancer Centre, 6National Cancer Research Institute (NCRI), 7Independent Cancer Patients’ Voice (ICPV), 8University Hospitals of Leicester NHS Trust, 9University Hospitals Birmingham NHS Foundation Trust, 10NHS Grampian – Aberdeen Royal Infirmary, 11University of Aberdeen, 12University of Leicester

The nuclear hormone receptor cofactors prohibitin-2 (PHB2) and tetratricopeptide repeat domain 5 (TTC5) exert opposite effects in breast tumorigenesis

Year:

Session type:

Kawther Almazroee1, Constantinos Demonacos1, Ayşe Latif1
1University of Manchester

Adrenal Insufficiency following Prolonged Exogenous Steroid Treatment for Graft Versus Host Disease

Year:

Session type:

Ann Tivey1, Henry Simons1, John Murray1, Claire Higham1
1The Christie NHS Foundation Trust

Optimising Supported Early Discharge Follow-up care for women with Breast Cancer in the UK – a qualitative analysis

Year:

Session type:

Lyndel Moore1, Eila Watson2, Lyndel Moore1, Lauren Matheson2, Jo Brett2, Verna Lavender3, Bernadette Lavery4, Anne Kendall1
1Great Western Hospital, 2Oxford Brookes University, 3Guy’s and St Thomas’ NHS Foundation Trust, 4Oxford University Hospitals NHS Foundation Trust

Alcohol intake and endogenous hormones in pre- and post-menopausal women: findings from the UK Biobank

Year:

Session type:

Sandar Tin Tin1, Timothy J Key1, Gillian K Reeves1
1University of Oxford

Patients’ experiences of a suppoRted self-manAGeMent pAThway In breast Cancer (PRAGMATIC): 3 month quality of life results

Year:

Session type:

Valerie Jenkins1, May Teoh2, Lucy Matthews2, Manish Kothari2, David Bloomfield2, Shirley May2, Charles Zammit2, Dibendu Betal2, Regina Santos2, Kay Nicholson2, Debbie Elwell-Sutton2, Fiona McKinna2, Heather Gage2, Stephanie Bell2
1University of Sussex, 2Other

Physical activity interventions and health-related quality of life in women with breast cancer: A systematic literature review of the World Cancer Research Fund/American Institute of Cancer Research

Year:

Session type:

Dagfinn Aune1, Georgios Markozannes1, Leila Abar1, Katia Balducci1, Margarita Cariolou1, Neesha Nanu1, Ana Rita Vieira1, Steven Clinton2, Edward L Giovannucci2, Marc J Gunter3, Alan Jackson4, Ellen Kampman2, Viv Lund2, Anne McTiernan5, Kate Allen6, Nigel Brockton7, Helen Crocker6, Daphne Katsikioti6, Deirdre McGinley-Gieser7, Panagiota Mitrou6, Martin Wiseman6, Galina Velikova2, Wendy Demark-Wahnefried8, Teresa Norat1, Konstantinos K Tsilidis1, Doris S.M. Chan1
1Imperial College London, 2Other, 3International Agency for Research on Cancer (IARC), 4University of Southampton, 5Fred Hutchinson Cancer Research Center, 6World Cancer Research Fund International, 7American Institute for Cancer Research, 8University of Alabama at Birmingham

Comprehensive evaluation of risk factors associated with immune checkpoint blockade-induced hepatitis

Year:

Session type:

Colin Lee1, Joanna Kucharczak1, Bruno De Paula1, George Mells1, Sarah Welsh1
1Cambridge University Hospitals NHS Foundation Trust

WHY spend time outdoors? Nature can aid psychosocial and emotional wellbeing in those living with or beyond cancer

Year:

Session type:

Moa Sundström1
1King’s College London (KCL)

A scoping review to determine levels of knowledge, attitudes and screening practices towards breast and cervical cancer among women in Nepal

Year:

Session type:

Candice Rademaker1, Helena Harder1
1Brighton and Sussex Medical School

A meta-ethnography of cultural and relational influences on cancer-related psychological interventions

Year:

Session type:

Damien Ridge1, Karen Pilkington2, Sheila Donovan3, Elisavet Moschopoulou3, Dipesh Gopal3, Kamaldeep Bhui4, Trudie Chalder5, Imran Khan3, Stephanie Taylor3, Ania Korszun3
1University of Westminster, 2University of Portsmouth, 3Queen Mary University of London, 4University of Oxford, 5King’s College London (KCL)

Investigating the oncogenic properties of HER2 splice variants in breast cancer.

Year:

Session type:

Victoria Hart1
1Newcastle University

Value of a simple neurocognitive test at GP Referral for CT scan for Headache Suspicious of Cancer – a “red flag” for tumour.

Year:

Session type:

Robin Grant1, Karolis Zeinius2, Will Hewins1, David Summers3, Lesley McKinlay3, Paul Brennan1, Lorna Porteous4
1University of Edinburgh, 2Hull Royal Infirmary, 3Royal Infirmary of Edinburgh, 4NHS Lothian

LARGEST SINGLE CENTRE SERIES OUTCOMES FOR WATCH AND WAIT (WW) IN RECTAL CANCER PATIENTS IN UNITED KINGDOM

Year:

Session type:

Rashi Mane1, Chris Rao1, Sandeep Kaul1
1Barking, Havering and Redbridge University Hospitals NHS Trust

Identification of a microbiome signature predicting immune checkpoint inhibitor outcomes across multiple cancer types: the MITRE study

Year:

Session type:

Pippa Corrie1, Sarah Welsh2, Grant Stewart2, Gary Doherty3, Kevin Vervier4, Anne Neville4, Christine Parkinson3, Kate Fife3, Guy Faust5, Kamalram Thippu Jayaprakash4, Thomas Geldart6, Ewan Brown7, Matthew Wheater8, Jenny Nobes9, Tania Tillett10, Toby Talbot11, Clare Barlow12, Helen Winter4, David Bruce3, Katy Dalchau3, Nikos Demiris3, David Adams13, Mat Robinson4, Trevor Lawley4
1Addenbrooke’s Hospital, 2University of Cambridge, 3Cambridge University Hospitals NHS Foundation Trust, 4Other, 5University Hospitals of Leicester NHS Trust, 6Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust, 7Western General Hospital, 8University Hospital Southampton NHS Foundation Trust, 9Norfolk & Norwich University Hospitals NHS Foundation Trust, 10Royal United Hospitals Bath NHS Foundation Trust, 11Royal Cornwall Hospitals NHS Trust, 12Somerset NHS Foundation Trust, 13Wellcome Sanger Institute

Comparative response of head and neck cancer cells to photons and protons: Optimising radiosensitivity through targeting the DNA damage response

Year:

Session type:

Jason Parsons1, Maria Rita Fabbrizi1, Rachel Carter1, Catherine Nickson1, Eirini-Terpsi Vitti1, Mark Hill2
1University of Liverpool, 2University of Oxford

Patterns of care of  first line systemic treatment of advanced renal cell cancer (aRCC) patients before and during the covid-19 pandemic

Year:

Session type:

Jessica Ball1, Amarnath Challapalli1, Zoe Hudson1, Amit Bahl1
1University Hospitals Bristol NHS Foundation Trust

Bone Health and Androgen Deprivation Therapy For Advanced Prostate Cancer: A Clinical Audit Report of Baseline FRAX Scores

Year:

Session type:

Jonathan Martin1, Simon Crabb2, Vanessa Basketter2
1University of Southampton, 2University Hospital Southampton NHS Foundation Trust

A North west London experience of use of Immunotherapeutic drugs in advanced renal cancer during COVID-19 pandemic

Year:

Session type:

Anand Sharma1, Salma Alam1, Joanne Kwa2, Yatri Shah1, Rebecca Devine1, Andrew Gogbashian3, Paul Nathan1
1Mount Vernon Cancer Centre, 2East and North Hertfordshire NHS Trust, 3Paul Strickland Scanner Centre

Multiplex blood and tissue biomarkers for early lung cancer detection in a population undergoing computed tomographic (CT) screening: the iDx-Lung study

Year:

Session type:

Michelle Chesters1, Peter Johnson1, Victoria Goss1, Jocelyn Walters1, Darran Ball1, Claire Eckert2, Sam Wilding1, Jacqueline Nuttall1, Kathy Potter1, Debora Joseph-Pietras1, Kate Rolfvondenbaumen1, Catherine Pointer1, Hang Phan1, Bethany Shinkins2, Philip Crosbie3, Kevin Franks4, Isabel Macdonald5, Graham Healey5, Helen Oxford6, Paul Smith4, Ravinder Pabial7, Duncan Whitney8, Matthew Callister4, Richard Neal2, Gareth Griffiths1
1University of Southampton, 2University of Leeds, 3University of Manchester, 4Other, 5Oncimmune, 6Inivata, 7Roche, 8Johnson & Johnson

Concerns of gynaecological cancer patients during the COVID-19 pandemic and the role of cancer charities in supporting them: an investigation of patient-charity interactions.

Year:

Session type:

Pratyusha Saha1, Jameela Sheikh1, Meghnaa Hebbar1, Sudha Sundar1, Anne Lanceley2
1University of Birmingham, 2University College London (UCL)

Primary results of phase 2 FOENIX-CCA2: the irreversible FGFR1–4 inhibitor futibatinib in intrahepatic cholangiocarcinoma (iCCA) with FGFR2 fusions/rearrangements

Year:

Session type:

John Bridgewater1, Funda Meric-Bernstam2, Antoine Hollebecque3, Chigusa Morizane4, Juan W. Valle5, Thomas B. Karasic4, Thomas A. Abrams6, Robin Kate Kelley4, Philippe Cassier4, Junji Furuse4, Heinz-Josef Klümpen4, Heung-Moon Chang7, Li-Tzong Chen4, Yoshito Komatsu4, Kunihiro Masuda4, Daniel Ahn8, Yaohua He4, Nital Soni4, Karim A. Benhadji4, Lipika Goyal4
1UCL, 2MD Anderson Cancer Center, 3Institut Gustave Roussy, 4Other, 5University of Manchester, 6Dana-Farber Cancer Institute, 7Asan Medical Center, 8Mayo Clinic

Patients’ experiences of a suppoRted self-manAGeMent pAThway In breast Cancer (PRAGMATIC)

Year:

Session type:

Valerie Jenkins1, May Teoh2, Lucy Matthews2, Shirley May2, Manish Kothari2, David Bloomfield2, Fiona McKinna2, Charles Zammit2, Debbie Elwood-Sutton2, Stephanie Bell2, Heather Gage2, Regina Santos2, Elaine Stewart2, Dibendu Betal2, Kay Nicholson2, Judith Finlay2
1University of Sussex, 2Other

Harnessing liver-resident gamma delta T cells for immunotherapy of hepatocellular carcinoma

Year:

Session type:

Nekisa Zakeri1, Andrew Hall1, Leo Swadling1, Laura J Pallett1, Nathalie M Schmidt1, Mariana O Diniz1, Stephanie Kucykowicz1, Oliver E Amin1, Amir Gander1, Massimo Pinzani2, Brian R Davidson2, Alberto Quaglia2, Mala K Maini1
1University College London (UCL), 2Royal Free London NHS Foundation Trust

Information Needs around Parenteral nUTrition in cancer: INPUT

Year:

Session type:

Jennifer McCracken1, Lucy Eldridge1, Angela Halley1, Sally Wheelwright2, Jane Hopkinson3, Sam H Ahmedzai4, Adrian Tookman5, John Louis-Auguste6, Rebecca Harmston7, Deb Smith7, Clare Shaw1
1Royal Marsden NHS Foundation Trust, 2University of Southampton, 3Cardiff University, 4University of Sheffield, 5Marie Curie, 6St George’s University Hospitals NHS Trust, 7Other

Evaluation of learning interpretation of abbreviated breast MRI in novice MRI readers as part of the UK FAST MRI research programme.

Year:

Session type:

Sadie McKeown-Keegan1, Jan Rose2, Elizabeth O’Flynn3, Lyn Jones2, Rebecca Geach1, Janet Dunn4, Andrea Marshall4, Sian Taylor-Philips4, Mark Halling-Brown5, Premkumar Elangovan6
1North Bristol NHS Trust, 2No affiliation, 3St George’s University Hospitals NHS Trust, 4University of Warwick, 5Royal Surrey NHS Foundation Trust, 6Royal Veterinary College